Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL)
一项由淋巴瘤生存改善联盟 (CISL) 开展的多中心随机 II 期研究表明，在复发或高危非霍奇金淋巴瘤患者的自体干细胞移植中，白消安、美法仑和依托泊苷 (BuME) 作为预处理疗法与白消安、环磷酰胺和依托泊苷 (BuCE) 具有同等疗效。
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2022.004
Kim, Kyoung Ha; Lee, Jae Hoon; Lee, Mark; Kim, Hoon-Gu; Do, Young Rok; Park, Yong; Oh, Sung Yong; Shin, Ho-Jin; Kim, Won Seog; Park, Seong Kyu; Kong, Jee Hyun; Park, Moo-Rim; Yang, Deok-Hwan; Kwak, Jae-Yong; Kang, Hye Jin; Mun, Yeung-Chul; Won, Jong-Ho
